Restfine
Restfine
- In our pharmacy, you can buy Restfine without a prescription, widely available online in India and various Asian countries.
- Restfine is used primarily for the treatment of insomnia. The drug works as a hypnotic agent by enhancing GABA activity in the brain, promoting sleep.
- The usual dose of Restfine is 7.5 mg taken orally at bedtime. For the elderly or debilitated patients, the recommended starting dose is 3.75 mg.
- The form of administration is a tablet.
- The effect of Restfine begins within 30 minutes after ingestion.
- The duration of action is typically 6-8 hours.
- Do not consume alcohol while using Restfine, as it can increase the sedative effects.
- The most common side effect is daytime drowsiness.
- Would you like to try Restfine without a prescription?
Restfine
Basic Restfine Information
- INN (International Nonproprietary Name)
- Brand names available in Canada
- ATC Code
- Forms & dosages (e.g., tablets, injections, creams)
- Manufacturers in Canada
- Registration status in Canada
- OTC / Rx classification
Restfine is the brand name for a medication that contains the active ingredient *zopiclone*, widely prescribed for the management of insomnia. Understanding the basic details surrounding Restfine can help individuals make informed decisions about its use. Below is an outline of essential information concerning this medication.
INN and Brand Names
The International Nonproprietary Name (INN) for this agent is zopiclone. In Canada, it is marketed under several brand names, primarily Restfine, Imovane, and Zimovane. Each brand may have different available strengths and formulations, which is crucial for patients to consider when consulting with their healthcare providers.
ATC Code and Classification
The medication carries the ATC Code N05CF01, categorizing it as a non-benzodiazepine hypnotic. This classification indicates its use in treating sleep disorders via a distinct mechanism that differentiates it from traditional benzodiazepines, potentially reducing certain side effects.
Dosage Forms Available
Restfine is available in multiple dosage forms to cater to different patient needs:
| Form | Strengths | Common Packaging |
|---|---|---|
| Tablet | 7.5 mg, 3.75 mg | 10 or 30 tablets per blister pack |
| Oral drops | 1 mg/ml | Bottles of 20 ml (limited markets) |
Manufacturers and Suppliers
Restfine is typically manufactured in India, while its alternative brand, Imovane, is produced in Canada by Sanofi. The global availability of these brands can differ based on regional regulations.
Registration Status
In terms of legal status, Restfine is classified as Rx-only in most regions, including Canada, which means a prescription is necessary for its procurement. In the European Union, it holds authorization from the EMA, further establishing its safety profile for patients during its usage.
OTC and Rx Classification
As a strict regulation, Restfine remains available by prescription only (Rx) in Canada and many other countries. This classification aims to ensure that the drug is used appropriately and monitored closely by healthcare professionals.
Safety & Warnings for Restfine
When considering the use of Restfine, which contains zopiclone, it’s crucial to be aware of potential risks and contraindications.
Contraindications
Certain conditions make zopiclone unsafe. Absolute contraindications include:
- Severe hepatic impairment
- Myasthenia gravis
- Severe respiratory insufficiency, such as sleep apnea syndrome
- Severe hepatic failure
- Hypersensitivity to zopiclone or any of its ingredients
Side Effects
While many patients tolerate Restfine well, side effects can occur. Common issues include:
- Dry mouth
- Headache
- Dizziness
- Gastrointestinal symptoms like nausea
More severe reactions are rare but can include central nervous system (CNS) depression, sleepwalking, and memory loss. If such symptoms emerge, immediate medical attention is advisable.
Special Precautions
Pregnant women and those with liver or kidney issues must approach zopiclone with caution. It's recommended to consult healthcare providers for tailored advice. Dependency risks warrant careful monitoring during treatment, especially for individuals with a history of substance abuse or other psychological conditions.
Black Box Warnings
Zopiclone has a black box warning due to the potential for profound sedation and respiratory depression. This risk is especially heightened in elderly individuals or those using other CNS depressants. Always follow dosing instructions closely to mitigate these risks.
Patient Experience with Restfine
Understanding how others have responded to Restfine provides valuable insight into its practical use. Feedback from platforms like Drugs.com and Reddit illustrates varied experiences.
Reviews
Many patients report relief from insomnia, finding Restfine effective in promoting sleep onset and maintenance. However, experiences regarding side effects differ significantly. Some report minimal issues like mild drowsiness, while others mention more notable concerns such as headaches and dry mouth.
User Feedback
Discussion in online forums highlights common themes. Users note the effectiveness of Restfine, particularly for short-term use. However, concerns arise about potential dependency when used beyond recommended durations.
Subjective Insights on Adherence
Adherence challenges are frequent among patients. Factors influencing this include side effects, individual perceptions of efficacy, and the fear of dependency. Some patients skip doses to avoid side effects, although this can compromise treatment outcomes.
Alternatives & Comparison with Restfine
For those seeking alternatives to Restfine, several options are available in Canada.
Common Alternatives
Notable alternatives include:
- Lunesta (Eszopiclone)
- Zolpidem (Stilnox)
- Zaleplon (Sonata)
Comparison Table
| Medication | Average Price (CAD) | Effectiveness | Safety Profile |
|---|---|---|---|
| Restfine | $30 for 30 tablets | Effective for most users | Risk of dependency |
| Lunesta | $40 for 30 tablets | Similar efficacy | Some abuse potential |
| Zolpidem | $35 for 30 tablets | Widely used | May cause complex sleep behaviors |
Local Doctor Preferences
Healthcare professionals often consider patients' specific needs when prescribing sleep aids. In general, Restfine is frequently recommended for its quick effectiveness, while alternatives like Lunesta and Zolpidem may be preferred in cases involving long-term management of insomnia.
Market Overview of Restfine in Canada
Understanding the market dynamics for Restfine can help potential users navigate their options effectively.
Availability
Restfine can typically be found at several pharmacies, including popular chains like Catena and HelpNet. It's advisable to call ahead to confirm stock availability.
Average Price
Pricing for Restfine hovers around $30 CAD for a 30-tablet supply, making it relatively affordable compared to some alternatives.
Packaging
Restfine generally comes in blister packs, with each tablet clearly marked for easy identification. This packaging is designed to ensure both safety and convenience.
Demand Patterns
Post-COVID, sleep disturbances have become increasingly common, leading to a heightened interest in sleep medications like Restfine. Many patients report struggling with sleep more than ever, making effective treatment options essential for public health.
Recent Research & Trends in Zopiclone
In the rapidly evolving world of sleep medications, recent meta-analyses and trials between 2022 and 2025 have highlighted the lingering efficacy of zopiclone, often marketed as Restfine. Studies conducted globally underline its effectiveness in reducing sleep latency and improving overall sleep quality, making it a key player in the treatment of insomnia. These findings reinforce the longstanding use of zopiclone as a frontline treatment, confirming its role alongside newer agents.
Interestingly, researchers are exploring experimental uses beyond typical insomnia treatment. Zopiclone is being investigated for potential applications in treating other conditions, such as anxiety disorders and specific chronic pain conditions. These studies aim to uncover zopiclone's broader therapeutic profile, thereby adjusting the perception of traditional sleep medications limited to solely managing insomnia.
Regarding its patent status, zopiclone remains under patent protection in some regions, which influences generic availability. However, in countries like India, generics are widely accessible, leading to lower costs and fostering increased patient access. This growing market for zopiclone generics may bring value to healthcare systems aiming to alleviate insomnia on a budget while ensuring patient safety.